7th annual ICE-HBV HBV cure symposium
Therapeutic Vaccines for Chronic Hepatitis B: Optimizing Their Utility in Novel Therapeutic Combinations
Chairs: Adam J. Gehring [Canada] and Anna D. Kosinska [Germany]
General Public ICE-HBV Symposium Registration
The ICE-HBV Symposium will take place on Sept. 6, 2026. If you are a member of the public who does not wish to register for the main HBV Meeting but would like to register for the ICE-HBV Symposium, please click the button below.
Schedule
3:00 – 3:10
Welcome address
Speaker: Adam Gehring
3:10 – 3:35
What we’ve learned, current strategies and future prospects for therapeutic vaccines.
Speaker: Anna Kosinska
3:35 – 4:00
Vaccine combinations in the current landscape of novel HBV therapies
Speaker: Seng Gee Lim
4:00 – 4:25
Does antigen reduction impact immunogenicity of therapeutic vaccines?
Speaker: Antonio Bertoletti
4:25 – 4:45
Coffee Break
4:45 – 5:05
How much would effective therapeutic vaccination improve functional cure rates?
Speaker: Adam Gehring
5:05 – 5:15
TherVacB – on the way to the clinic
Speaker: Ulrike Protzer
5:05 – 5:15
Immunogenicity of GS-2829 and GS-6779 in CHB patients with a broad range of baseline HBsAg levels.
Speaker: Simon Fletcher
5:25 – 5:35
Immunogenicity and long-term antiviral effect of VRON-0200
Speaker: Sue Currie
5:35 – 6:00
Round table discussion